Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Regional Insights and Engagement Director NSCLC, West is a field-based position focused on working closely with Lung Cancer Key Opinion Leaders (KOLs) at select institutions and accounts within the defined geography. This person is a RevMed clinical and product expert for Key Opinion Leaders and ensures that cross-functional resources are made available as appropriate. In this role, you will be a member of the commercial development team, and you will work closely with marketing, medical affairs, field sales, insights and analytics and other cross functional colleagues. You will help inform brand strategy, develop and execute KOL tactics and you will be evaluated in conjunction with individual performance and brand KPIs. This role will cover major academic institutions, accounts, and the Lung Key Opinion Leaders located in Northern and Southern California, Seattle, Houston, St. Louis, and Chicago. Candidates should ideally reside within an hour drive of one of these cities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
501-1,000 employees